How long does it take to become resistant to Adagrasib?

AdagrasibResistance is a complex issue that is affected by multiple factors, including genetic variation in the tumor, biological differences in individual patients, and the characteristics of the drug itself. Drug resistance is a common challenge for many anti-tumor drugs because tumor cells may gradually adapt to the drug during treatment, thereby reducing its efficacy.

For adagrasib, current clinical data cannot provide definite information indicating that patients will become resistant after using it for a period of time. The development of drug resistance is usually a gradual process that may involve new mutations or other adaptive mechanisms within tumor cells. Scientists and doctors are conducting research to gain a deeper understanding of the mechanisms of resistance to adagrasib and how to better manage and prevent the occurrence of resistance.

In clinical practice, a common strategy is to monitor genetic changes in tumors and adjust treatment regimens early when signs of resistance appear. This may include changing the medication dose, switching to other treatments, or combining other treatments to increase effectiveness.

Regarding the specific resistance data of adagrasiib, patients are advised to consult their doctors, as doctors will be able to provide them with more detailed information based on the patient's specific situation and the latest research data. In addition, the scientific community's research on tumor treatment is constantly progressing, and new treatment strategies and drugs may provide more options for drug resistance management.

Adagrasib is not currently available in the country, so patients cannot purchase it domestically and can only purchase adagrasib through overseas channels. Abroad, there is only the original American drug adagrasib, and the price is very high, as high as about 190,000 yuan.